[关键词]
[摘要]
目的 探讨心脑宁胶囊联合丁咯地尔治疗脑供血不足性眩晕症的临床疗效。方法 选取2017年8月—2018年8月在天津市宝坻区人民医院治疗的脑供血不足性眩晕症患者86例,根据住院号分为对照组(43例)和治疗组(43例)。对照组口服盐酸丁咯地尔片,0.3 g/次,2次/d;治疗组在对照组基础上口服心脑宁胶囊,3/粒,3次/d。两组患者均治疗4周。观察两组患者临床疗效,同时比较治疗前后两组患者眩晕评分、FS-CSA评分、脑多普勒超声(TCD)结果和血清学指标水平。结果 治疗后,对照组临床有效率为81.40%,显著低于治疗组的97.67%,两组比较差异具有统计学意义(P<0.05)。治疗后,两组患者眩晕评分显著升高(P<0.05),FS-CSA评分显著降低(P<0.05),且治疗组眩晕评分和FS-CSA评分明显好于对照组(P<0.05)。治疗后,两组椎动脉和基底动脉的平均血流速度(Vm)显著升高(P<0.05),椎动脉和基底动脉的脉动指数(PI)显著降低(P<0.05),且治疗组TCD结果明显好于对照组(P<0.05)。治疗后,两组患者血小板活化因子(PAF)、血栓素B2(TXB2)、白细胞介素-8(IL-8)水平显著降低(P<0.05),且治疗组PAF、TXB2、IL-8水平明显低于对照组(P<0.05)。结论 心脑宁胶囊联合盐酸丁咯地尔片治疗脑供血不足性眩晕症可有效改善患者临床症状,改善血流动力学指标,降低血清PAF、TXB2、IL-8水平。
[Key word]
[Abstract]
Objective To explore the clinical efficacy of Xinnaoning Capsules combined with buflomedil in treatment of cerebral insufficiency vertigo. Methods Patients (86 cases) with cerebral insufficiency vertigo in Tianjin Baodi hospital from August 2017 to August 2018 were divided into control (43 cases) and treatment (43 cases) groups based on different admission number. Patients in the control group were po administered with Buflomedil Hydrochloride Tablets, 0.3 g/time, twice daily. Patients in the treatment group were po administered with Xinnaoning Capsules on the basis of the control group, 3 grains/time, three times daily. Patients in two groups were treated for 4 weeks. After treatment, the clinical efficacy was evaluated, and the vertigo scores, FS-CSA scores, TCD results and serological indexes levels in two groups before and after treatment were compared. Results After treatment, the clinical efficacy in the control group was 81.40%, which was significantly lower than 97.67% in the treatment group, and there were differences between two groups (P<0.05). After treatment, the vertigo scores in two groups were significantly increased (P<0.05), but FS-CSA scores were significantly decreased (P<0.05), and these scores in the treatment group were significantly better than those in the control group (P<0.05). After treatment, the Vm of vertebral artery and basilar artery in two groups was significantly increased (P<0.05), the PI of vertebral artery and basilar artery was significantly decreased (P<0.05), and the TCD results in the treatment group was significantly better than that in the control group (P<0.05). After treatment, the PAF, TXB2 and IL-8 levels in two groups were significantly decreased (P<0.05), and which in the treatment group were significantly lower than those in the control group (P<0.05). Conclusion Xinnaoning Capsules combined with buflomedil in treatment of cerebral insufficiency vertigo can effectively improve the clinical symptoms, improve hemodynamic indicators, reduce serum levels of PAF, TXB2, IL-8.
[中图分类号]
[基金项目]